We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
-2.22%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$5.91M
(+0.55%)
Cap. Flow
+$69.6M
Cap. Flow
% of AUM
6.48%
Top 10 Holdings %
Top 10 Hldgs %
36.46%
Holding
509
New
13
Increased
172
Reduced
270
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$12.7M |
| 2 |
Amazon
AMZN
|
+$9.6M |
| 3 |
Microsoft
MSFT
|
+$7.09M |
| 4 |
Analog Devices
ADI
|
+$4.96M |
| 5 |
Broadcom
AVGO
|
+$4.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Silver Trust
SLV
|
+$7.41M |
| 2 |
ProShares Ultra Gold
UGL
|
+$6.74M |
| 3 |
Arista Networks
ANET
|
+$6.7M |
| 4 |
Gilead Sciences
GILD
|
+$4.85M |
| 5 |
TSMC
TSM
|
+$4.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.93% |
| 2 | Healthcare | 24.36% |
| 3 | Consumer Discretionary | 11.82% |
| 4 | Communication Services | 11.17% |
| 5 | Consumer Staples | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Agios Pharmaceuticals
AGIO
$2.04B
| $337K | 0.03% |
11,493
-599
| -5% | -$19.9K |
|
277
Beam Therapeutics
BEAM
$2.76B
| $332K | 0.03% |
17,022
-772
| -4% | -$20.2K |
|
|
DVAX
278
DELISTED
Dynavax Technologies
DVAX
| $323K | 0.03% |
24,886
-2,987
| -11% | -$39.5K |
|
279
MongoDB
MDB
$35.2B
| $323K | 0.03% |
1,839
+637
| +53% | +$155K |
|
280
Arrowhead Research
ARWR
$12.3B
| $322K | 0.03% |
25,293
-1,092
| -4% | -$19.9K |
|
281
Janux Therapeutics
JANX
$1.02B
| $320K | 0.03% |
11,855
+727
| +7% | +$27.4K |
|
282
Travere Therapeutics
TVTX
$5.86B
| $319K | 0.03% |
17,800
-406
| -2% | -$8.24K |
|
283
BioCryst Pharmaceuticals
BCRX
$2.71B
| $314K | 0.03% |
41,914
-2,006
| -5% | -$16.2K |
|
284
Vera Therapeutics
VERA
$2.16B
| $307K | 0.03% |
12,787
-640
| -5% | -$20.6K |
|
285
MannKind Corp
MNKD
$1.24B
| $306K | 0.03% |
60,895
+2,420
| +4% | +$13.6K |
|
286
ANI Pharmaceuticals
ANIP
$1.73B
| $292K | 0.03% |
4,365
-92
| -2% | -$5.5K |
|
|
ZK
287
DELISTED
Zeekr
ZK
| $289K | 0.03% |
12,000
| – | – |
|
288
IDEAYA Biosciences
IDYA
$3.56B
| $288K | 0.03% |
17,558
-769
| -4% | -$16.4K |
|
289
Amphastar Pharmaceuticals
AMPH
$850M
| $280K | 0.03% |
9,644
-551
| -5% | -$17.6K |
|
290
Invesco QQQ Trust
QQQ
$481B
| $277K | 0.03% |
590
+79
| +15% | +$40.1K |
|
|
CNTA
291
DELISTED
Centessa Pharmaceuticals
CNTA
| $263K | 0.02% |
18,311
-598
| -3% | -$9.79K |
|
292
Inspire Medical Systems
INSP
$1.68B
| $251K | 0.02% |
1,574
| – | – |
|
293
ARS Pharmaceuticals
SPRY
$601M
| $245K | 0.02% |
19,494
-1,113
| -5% | -$13.4K |
|
294
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $239K | 0.02% |
426
-144
| -25% | -$84.6K |
|
295
Dyne Therapeutics
DYN
$4.89B
| $237K | 0.02% |
22,690
+1,115
| +5% | +$15.9K |
|
296
Indivior Pharmaceuticals
INDV
$4.57B
| $237K | 0.02% |
24,900
-4,006
| -14% | -$42.1K |
|
297
Immunocore
IMCR
$1.77B
| $236K | 0.02% |
7,947
-446
| -5% | -$13.4K |
|
298
Ardelyx
ARDX
$1.03B
| $235K | 0.02% |
47,810
-2,412
| -5% | -$13K |
|
299
Hilton Worldwide
HLT
$72.6B
| $232K | 0.02% |
1,021
-6,614
| -87% | -$1.65M |
|
300
Ocular Therapeutix
OCUL
$2.25B
| $231K | 0.02% |
31,535
-1,801
| -5% | -$13.8K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q1 2025 Portfolio in Review
As of Q1 2025, China Universal Asset Management Company held 509 positions worth $1.07B, up 0.55% from $1.07B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
China Universal Asset Management Company deployed $69.6M of net new capital in Q1 2025, opening 13 new positions and adding to 172 existing holdings. Its largest new stake was VNET Group: 300,000 shares worth $2.46M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Silver Trust, an estimated $7.41M trimmed.
- China Universal Asset Management Company's largest Q1 2025 buy was VNET Group: 300,000 shares worth $2.46M.
- China Universal Asset Management Company added most to Apple in Q1 2025, an estimated $12.7M increase.
- China Universal Asset Management Company's biggest Q1 2025 reduction was iShares Silver Trust, cutting an estimated $7.41M.
- China Universal Asset Management Company fully exited Arista Networks in Q1 2025, selling an estimated $6.7M.
- China Universal Asset Management Company's ten largest holdings make up 36% of its $1.07B portfolio in Q1 2025.
- China Universal Asset Management Company opened 13 new positions and closed 23 in Q1 2025.
- China Universal Asset Management Company's portfolio value rose 0.55% quarter-over-quarter to $1.07B.
Based on China Universal Asset Management Company's 13F filing for Q1 2025, filed 30 Apr 2025.